APIDRA insulin glulisine (rbe) 100IU/mL 10mL injection vial

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 7bcefdcfd39a464b
Product Name: APIDRA insulin glulisine (rbe) 100IU/mL 10mL injection vial
Artg Id: 99145
Artg Name: APIDRA insulin glulisine (rbe) 100IU/mL 10 mL injection vial
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2005-05-02
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/a63042cf423fb3df3be10b37e5dd397b.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/8fc10c65f158c7ac80ef795ec9e511ae.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

7bcefdcfd39a464b

Type

Standard